October 29, 2021
James Feliciano, Chair, PhRMA Japan-based Executive Committee PhRMA is still considering its position on a proposal made by the Institute for New Era Strategy (INES) on the Japanese drug pricing system, but is clearly opposing any “cherry picking” by the...read more